Evaluation of the CEDIA(tm) dau assays and the AxSym(tm) system for the analysis of cannabinoids in whole blood

9Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The Microgenics CEDIA DAU (EIA) and the Abbott AxSym system (FPIA) cannabinoids assays were evaluated for their combined effectiveness in the analysis of cannabinoids in whole blood. Blood samples were treated with acetone, evaporated, and reconstituted, and the supernatant was analyzed by the EIA cannabinoids assay. Blood samples determined positive by EIA were then treated with acelonitrile and sodium sulfate, and the resultant protein- free supernatant was analyzed using the FPIA cannabinoids assay. A total of 98 blood samples determined to be presumptively positive by both EIA and FPIA were further analyzed for the presence of 11-nor-carboxy-Δ9- tetrahydrocannabinol-9-carboxylic acid (THCCOOH). All 98 blood samples could be confirmed for the presence of THCCOOH by gas chromatography-mass spectrometry (GC-MS) at concentrations greater than the 10 ng/mL cutoff. The GC-MS results were found to correlate significantly better with those of the FPIA cannabinoids assay (r = 0.75) than with EIA (r = 0.22). Procedures for the rapid analysis of whole blood for cannabinoids using CEDIA DAU reagents and the AxSym system are presented.

References Powered by Scopus

Screening for drugs in forensic blood samples using EMIT<sup>®</sup> urine assays

58Citations
N/AReaders
Get full text

A novel procedure for the analysis of drugs in whole blood by homogeneous enzyme immunoassay (EMIT®)

53Citations
N/AReaders
Get full text

Direct detection of drugs of abuse in whole hemolyzed blood using the emit d.A.u. urine assays

41Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Evaluation of immunochemical drug screenings of whole blood samples. A retrospective optimization of cutoff levels after confirmation-analysis on GC-MS and HPLC-DAD

28Citations
N/AReaders
Get full text

Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in whole blood of drivers involved in road accidents

16Citations
N/AReaders
Get full text

Direct semiquantitative screening of drugs of abuse in serum and whole blood by means of CEDIA® DAU urine immunoassays

16Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Cagle, J. C., McCurdy, H. H., Pan, Y. M., Ayton, K. J., Wall, W. H., & Solomons, E. T. (1997). Evaluation of the CEDIA(tm) dau assays and the AxSym(tm) system for the analysis of cannabinoids in whole blood. Journal of Analytical Toxicology, 21(3), 213–217. https://doi.org/10.1093/jat/21.3.213

Readers over time

‘12‘15‘16‘18‘19‘20‘21‘2302468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

83%

Researcher 1

17%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

40%

Pharmacology, Toxicology and Pharmaceut... 1

20%

Chemistry 1

20%

Agricultural and Biological Sciences 1

20%

Save time finding and organizing research with Mendeley

Sign up for free
0